| [1] |
Mantovani A, Savino B, Locati M, et al. The chemokine system in cancer biology and therapy[J]. Cytokine Growth Factor Rev, 2010,21(1):27-39.
|
| [2] |
Zlotnik A. Chemokines and cancer[J]. Int J Cancer, 2006,119(9):2026-2029.
|
| [3] |
Braun SE, Chen K, Foster RG, et al. The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK-cells [J]. J Immunol, 2000,164(8):4025-4031.
|
| [4] |
Wang JM, Chertov O, Proost P, et al. Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NF kappa B activation[J]. Int J Cancer, 1998,75(6):900-907.
|
| [5] |
Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001,410(6824):50-56.
|
| [6] |
Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis[J]. Nature, 2007,449(7162):557-563.
|
| [7] |
Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors[J]. Clin Exp Metastasis,2008,25(4):345-356.
|
| [8] |
Wong D, Korz W. Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside[J]. Clin Cancer Res, 2008,14(24):7975-7980.
|
| [9] |
Anders HJ, Sayyed SA, Vielhauer V. Questions about chemokine and chemokine receptor antagonism in renal inflammation[J]. Nephron Exp Nephrol, 2010,114(2):e33-e38.
|
| [10] |
Horuk R. Chemokine receptor antagonists: overcoming developmental hurdles [J]. Nat Rev Drug Discov, 2009,8(1):23-33.
|
| [11] |
Mantovani A, Garlanda C, Locati M, et al. Regulatory pathways in inflammation [J]. Autoimmun Rev, 2007,7(1):8-11.
|
| [12] |
Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor [J]. Science, 1993,261(5125):1182-1184.
|
| [13] |
Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo[J]. Nat Immunol, 2005,6(4):403-411.
|
| [14] |
Martinez de la Torre Y, Locati M, Buracchi C, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6[J]. Eur J Immunol, 2005,35(5):1342-1346.
|
| [15] |
Petrek M. Analysis of chemokine gene expression in lung cells by polymerase chain reaction[J]. Acta Univ Palacki Olomuc Fac Med, 1999,142:127-134.
|
| [16] |
Wang J, Ou ZL, Hou YF, et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential[J]. Oncogene, 2006,25(54):7201-7211.
|
| [17] |
刘小丰, 欧周罗, 邵志敏. 汉族女性乳腺疾病患者的Duffy 表型多态性与乳腺癌的关系[J]. 中国癌症杂志, 2007,17(12):935-938.
|
| [18] |
Bandyopadhyay S, Zhan R, Chaudhuri A, et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression[J]. Nat Med, 2006,12(8):933-938.
|
| [19] |
Hansell CA, Simpson CV, Nibbs RJ. Chemokine sequestration by atypical chemokine receptors[J]. Biochem Soc Trans,2006,34(Pt 6):1009-1013.
|
| [20] |
Nibbs RJ, Gilchrist DS, King V, et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors[J]. J Clin Invest, 2007,117(7):1884-1892.
|
| [21] |
Vetrano S, Borroni EM, Sarukhan A, et al. The lymphatic system controls intestinal inflammation and inflammationassociated colon cancer through the chemokine decoy receptor D6[J]. Gut, 2010,59(2):197-206.
|
| [22] |
Wu FY, Ou ZL, Feng LY, et al. Chemokine decoy receptor d6 plays a negative role in human breast cancer[J]. Mol Cancer Res, 2008,6(8):1276-1288.
|
| [23] |
Cheng X, Hung MC. Regulation of breast cancer metastasis by atypical chemokine receptors[J]. Clin Cancer Res, 2009,15(9):2951-2953.
|
| [24] |
Feng LY, Ou ZL, Wu FY, et al. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth,metastasis and patient survival[J]. Clin Cancer Res, 2009,15(9):2962-2970.
|
| [25] |
Zeng XH, Ou ZL, Yu KD, et al. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes[J]. Breast Cancer Res Treat, 2011,125(3):715-727.
|
| [26] |
Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more[J]. Nat Rev Immunol, 2006,6(12):907-918.
|
| [27] |
Deruaz M, Frauenschuh A, Alessandri AL, et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity[J]. J Exp Med, 2008,205(9):2019-2031.
|
| [28] |
Castor MG, Rezende B, Resende CB, et al. The CCL3/macrophage inflammatory protein-1alpha-binding protein evasin-1 protects from graft-versus-host disease but does not modify graft-versus-leukemia in mice[J]. J Immunol, 2010,184(5):2646-2654.
|
| [29] |
Montecucco F, Lenglet S, Braunersreuther V, et al. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice[J]. Arterioscler Thromb Vasc Biol, 2010,30(7):1371-1377.
|